Macul Ferreira de Barros, Pedro http://orcid.org/0000-0002-1958-876X
do Rosário, Maria Conceição
Szejko, Natalia
Polga, Natália
Requena, Guaraci de Lima
Ravagnani, Beatriz
Fatori, Daniel
Batistuzzo, Marcelo Camargo
Hoexter, Marcelo Queiroz
Rohde, Luis Augusto
Polanczyk, Guilherme Vanoni
Leckman, James Frederick
Miguel, Eurípedes Constantino
de Alvarenga, Pedro Gomes
Funding for this research was provided by:
Fundação de Amparo à Pesquisa do Estado de São Paulo
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Article History
Received: 30 August 2019
Accepted: 7 February 2020
First Online: 19 February 2020
Compliance with ethical standards
:
: Pedro Macul Ferreira de Barros, Natalia Szejko, Natália Polga, Guaraci de Lima Requena, Ana Beatriz Ravagnani Salto, Daniel Fatori, Marcelo Camargo Batistuzzo, Marcelo Queiroz Hoexter, Eurípedes Constantino Miguel and Pedro Gomes de Alvarenga declare no conflicts of interest. Maria Conceição do Rosário has served on the speakers’ bureau of Novartis and Shire, and declares no potential conflicts of interest relating to this research. Luis Augusto Rohde has received grant or research support from, served as a consultant to, and served on the speakers’ bureau of Eli Lilly and Co., Janssen, Medice, Novartis, and Shire. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by Dr. Rohde have received unrestricted educational and research support from the following pharmaceutical companies: Eli Lilly and Co., Janssen, Shire, and Novartis. Dr. Rohde has received travel grants from Shire to take part in the 2018 American Psychological Association annual meeting and from Novartis to take part of the 2016 American Academy of Child and Adolescent Psychiatry annual meeting. He also has received authorship royalties from Oxford Press and ArtMed, and declares no potential conflicts of interest relating to this research. Guilherme Vanoni Polanczyk has served as a consultant or speaker to Shire, Teva, and Medice, has received royalties from Editora Manole, and declares no potential conflicts of interest relating to this research. James Frederick Leckman receives royalties from John Wiley and Sons, McGraw Hill, and Oxford University Press; is on the Advisory Boards for Brain and Behavior Research Foundation and How I Decide; has served as a consultant for Tasly Pharmaceuticals, Inc., and declares no potential conflicts of interest relating to this research.